Microscopy and latex antigen negative cryptococcal meningitis

Journal of Infection

Volumn 36, Issue 3, 1998, Pages 329-331

  Laurenson, I F ^a   Ross, J D C ^b   Milne, L J R ^c  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^c WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; LATEX;

ADOLESCENT; ARTICLE; CASE REPORT; CEREBROSPINAL FLUID CULTURE; CRYPTOCOCCUS NEOFORMANS; DIAGNOSTIC ERROR; FUNGAL MENINGITIS; HEAT TREATMENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LATEX AGGLUTINATION TEST; MALE; MICROSCOPY; NEUTROPHIL; URINE CULTURE; YEAST;

EID: 0031841113     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-4453(98)94567-4     Document Type: Article

References (17)

1. Dismukes WE. Cryptococcal meningitis in patients with AIDS. J Infect Dis 1988; 157: 624-628.
2. Knight FR, Mackenzie DW, Evans BG, Porter K, Barrett NJ, White GC. Increasing incidence of cryptococcosis in the United Kingdom. J Infect 1993; 27: 185-191.
3. Vartivarian SE, Anaissie EJ, Cowart RE, Sprigg HA, Tingler MJ, Jacobson ES. Regulation of cryptococcal capsular polysaccharide by iron. J Infect Dis 1993; 167: 186-190.
4. Dykstra MA, Friedman L, Murphy JW. Capsule size of Cryptococcus neoformans: control and relation to cirulence. Infection & Immunity 1977; 16: 129-135.
5. Kwon-Chung KJ, Rhodes JC. Encapsulation and melanin formation as indicators of virulence in Cryptococcus neoformans. Infection & Immunity 1986; 51: 218-223.
6. Kozel TR, Hermerath CA. Binding of cryptococcal polysaccharide to Cryptococcus neoformans. Infection & Immunity 1984; 43: 879-886.
7. Drouhet E, Segretain G. Inhibition de la migration leucocytaire in vitro par un polyoside capsulaire de Torulopsis (Cryptococcus) neoformans. Annales de l'Institut Pasteur 1951; 81: 674-676.
8. Khakpour FR, Murphy JW. Characterization of a third-order suppressor T cell (Ts3) induced by cryptococcal antigen(s). Infection & Immunity 1987; 55: 1657-1662.
9. Vecciarelli A, Retini C, Pietrella D et al. Purified capsular polysaccharide of Cryptococcus neoformans induces interleukin-10 secretion by human monocytes. Infection & Immunity 1996; 64: 2846-2849.
10. Retini C, Vecchiarelli A, Monari C, Tascini C, Bistoni F, Kozel TR. Capsular polysaccharide of Cryptococcus neoformans induces proinflammatory cytokine release by human neutrophils. Infection & Immunity 1996; 64: 2897-2903.
11. Pettoello-Mantovani M, Casadevall A, Kollmann TR, Rubenstein A, Goldstein H. Enhancement of HIV-1 infection by the capsular polysaccharide of Cryptococcus neoformans. Lancet 1992; 339: 21-23.
12. Kozel TR, Wilson MA, Welch WH. Kinetic analysis of the amplification phase for activation and binding of C3 to encapsulated and nonencapsulated Cryptococcus neoformans. Infection & Immunity 1992; 60: 3122-3127.
13. Chuck SL, Sande MA. Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. N Eng J Med 1989; 321: 794-799.
14. Currie BP, Freundlich LF, Soto MA, Casadevall A. False-negative cerebrospinal fluid cryptococcal latex agglutination tests for patients with culture-positive cryptococcal meningitis. J Clin Microbiol 1993; 31: 2519-2522.
15. Sadamoto S, Ikeda R, Nishikawa A, Shinoda T. Evidence for interference by immune complexes in the serodiagnosis of cryptococcosis. Microbiol & Immunol 1993; 37: 129-133.
16. Tanner DC, Weinstein MP, Fedorciw B, Joho KL, Thorpe JJ, Relier LB. Comparison of commercial kits for detection of cryptococcal antigen. J Clin Microbiol 1994; 32: 1680-1684.
17. Collins HL. Bancroft GJ. Encapsulation of Cryptococcus neoformans impairs antigen-specific T-cell responses. Infection & Immunity 1991; 59: 3883-3888.